Left ventricular free wall (LVFW)

The left ventricular free wall is the thick, muscular portion of the heart's left ventricle that does not include the interventricular septum. It is primarily composed of cardiomyocytes and is responsible for generating the high systemic pressure required to pump oxygenated blood throughout the body (StatPearls, 2023). While not a specific molecular target such as a receptor or enzyme, it is the anatomical site where many cardiovascular drugs exert their effects to manage heart failure, hypertension, and myocardial infarction (PubMed, 2021). Pathological changes in this region, such as hypertrophy or thinning, are key indicators of cardiovascular disease progression. A particularly severe complication is left ventricular free wall rupture (LVFWR), which can occur following a transmural myocardial infarction and is often fatal without immediate surgical intervention (NIH, 2022). Clinical management of the left ventricular free wall involves using drugs like beta-blockers to reduce wall stress and ACE inhibitors to prevent adverse remodeling (Journal of the American College of Cardiology, 2020).

Other names

LV free wallLeft ventricle free wall

Pharmacological agents do not target the wall as a single molecule but instead modulate the physiological activity of the myocardium within the wall, such as altering contractility via inotropes or reducing afterload and wall stress via vasodilators and beta-blockers.